A citation-based method for searching scientific literature

K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay, S Balasingham, L Verity, A Eisen, B Curpen, R Shumak, D B Plewes, S A Narod. Br J Cancer 2012
Times Cited: 109







List of co-cited articles
742 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, A K Dixon, D F Easton, R A Eeles, D G R Evans, F J Gilbert, I Griebsch, R J C Hoff, P Kessar,[...]. Lancet 2005
693
44

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Peter E Besnard, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Hans Peterse, Madeleine M A Tilanus-Linthorst,[...]. N Engl J Med 2004
40

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Ellen Warner, Donald B Plewes, Kimberley A Hill, Petrina A Causer, Judit T Zubovits, Roberta A Jong, Margaret R Cutrara, Gerrit DeBoer, Martin J Yaffe, Sandra J Messner,[...]. JAMA 2004
760
37

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Christiane K Kuhl, Simone Schrading, Claudia C Leutner, Nuschin Morakkabati-Spitz, Eva Wardelmann, Rolf Fimmers, Walther Kuhn, Hans H Schild. J Clin Oncol 2005
640
36

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
36

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Ellen Warner, Kimberley Hill, Petrina Causer, Donald Plewes, Roberta Jong, Martin Yaffe, William D Foulkes, Parviz Ghadirian, Henry Lynch, Fergus Couch,[...]. J Clin Oncol 2011
156
34

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Christiane Kuhl, Stefanie Weigel, Simone Schrading, Birke Arand, Heribert Bieling, Roy König, Bernd Tombach, Claudia Leutner, Andrea Rieber-Brambs, Dennis Nordhoff,[...]. J Clin Oncol 2010
261
27

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
26

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Adriana J Rijnsburger, Inge-Marie Obdeijn, Reinoutje Kaas, Madeleine M A Tilanus-Linthorst, Carla Boetes, Claudette E Loo, Martin N J M Wasser, Elisabeth Bergers, Theo Kok, Sara H Muller,[...]. J Clin Oncol 2010
111
25

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Francesco Sardanelli, Franca Podo, Filippo Santoro, Siranoush Manoukian, Silvana Bergonzi, Giovanna Trecate, Daniele Vergnaghi, Massimo Federico, Laura Cortesi, Stefano Corcione,[...]. Invest Radiol 2011
194
22

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Ellen Warner, Hans Messersmith, Petrina Causer, Andrea Eisen, Rene Shumak, Donald Plewes. Ann Intern Med 2008
324
20

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Constance D Lehman, Jeffrey D Blume, Paul Weatherall, David Thickman, Nola Hylton, Ellen Warner, Etta Pisano, Stuart J Schnitt, Constantine Gatsonis, Mitchell Schnall,[...]. Cancer 2005
258
19

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
19

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
836
18

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
132
17

MRI breast screening in high-risk women: cancer detection and survival analysis.
D Gareth Evans, Nisha Kesavan, Yit Lim, Soujanye Gadde, Emma Hurley, Nathalie J Massat, Anthony J Maxwell, Sarah Ingham, Rosalind Eeles, Martin O Leach,[...]. Breast Cancer Res Treat 2014
74
21

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.
Kathryn P Lowry, Janie M Lee, Chung Y Kong, Pamela M McMahon, Michael E Gilmore, Jessica E Cott Chubiz, Etta D Pisano, Constantine Gatsonis, Paula D Ryan, Elissa M Ozanne,[...]. Cancer 2012
58
25

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Wendie A Berg, Zheng Zhang, Daniel Lehrer, Roberta A Jong, Etta D Pisano, Richard G Barr, Marcela Böhm-Vélez, Mary C Mahoney, W Phil Evans, Linda H Larsen,[...]. JAMA 2012
557
15

Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI.
Christiane K Kuhl, Simone Schrading, Kevin Strobel, Hans H Schild, Ralf-Dieter Hilgers, Heribert B Bieling. J Clin Oncol 2014
274
15

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
828
15

Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.
Anne I Hagen, Kjell Arne Kvistad, Lovise Maehle, Marit Muri Holmen, Hildegunn Aase, Bodil Styr, Anita Vabø, Jaran Apold, Per Skaane, Pål Møller. Breast 2007
117
14

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study.
Constance D Lehman, Claudine Isaacs, Mitchell D Schnall, Etta D Pisano, Susan M Ascher, Paul T Weatherall, David A Bluemke, Deborah J Bowen, P Kelly Marcom, Deborah K Armstrong,[...]. Radiology 2007
238
13

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Eveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, Madeleine M A Tilanus-Linthorst, Gareth Evans, Petrina A Causer, Rosalind A Eeles, Reinie Kaas, Gerrit Draisma, Elizabeth A Ramsay,[...]. Cancer Epidemiol Biomarkers Prev 2012
51
25

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
487
13

Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
Carol H Lee, D David Dershaw, Daniel Kopans, Phil Evans, Barbara Monsees, Debra Monticciolo, R James Brenner, Lawrence Bassett, Wendie Berg, Stephen Feig,[...]. J Am Coll Radiol 2010
408
13

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
12

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
698
11

Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Anna M Chiarelli, Maegan V Prummel, Derek Muradali, Vicky Majpruz, Meaghan Horgan, June C Carroll, Andrea Eisen, Wendy S Meschino, Rene S Shumak, Ellen Warner,[...]. J Clin Oncol 2014
62
17

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis.
Xuan-Anh Phi, Nehmat Houssami, Inge-Marie Obdeijn, Ellen Warner, Francesco Sardanelli, Martin O Leach, Christopher C Riedl, Isabelle Trop, Madeleine M A Tilanus-Linthorst, Rodica Mandel,[...]. J Clin Oncol 2015
39
28

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010
153
10

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
10

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
Francesco Sardanelli, Carla Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Fiona J Gilbert, Thomas Helbich, Sylvia H Heywang-Köbrunner, Werner A Kaiser, Michael J Kerin,[...]. Eur J Cancer 2010
514
10

Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
Francesco Sardanelli, Franca Podo, Giuliano D'Agnolo, Arduino Verdecchia, Mariano Santaquilani, Renato Musumeci, Giovanna Trecate, Siranoush Manoukian, Sandro Morassut, Clelia de Giacomi,[...]. Radiology 2007
240
10

Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
Huong T Le-Petross, Gary J Whitman, Deanne P Atchley, Ying Yuan, Angelica Gutierrez-Barrera, Gabriel N Hortobagyi, Jennifer K Litton, Banu K Arun. Cancer 2011
48
18

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.
Wendie A Berg, Jeffrey D Blume, Jean B Cormack, Ellen B Mendelson, Daniel Lehrer, Marcela Böhm-Vélez, Etta D Pisano, Roberta A Jong, W Phil Evans, Marilyn J Morton,[...]. JAMA 2008
802
9


Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
477
9

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.
Jessica E Cott Chubiz, Janie M Lee, Michael E Gilmore, Chung Y Kong, Kathryn P Lowry, Elkan F Halpern, Pamela M McMahon, Paula D Ryan, G Scott Gazelle. Cancer 2013
43
20

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
657
9

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.
B A M Heemskerk-Gerritsen, M B E Menke-Pluijmers, A Jager, M M A Tilanus-Linthorst, L B Koppert, I M A Obdeijn, C H M van Deurzen, J M Collée, C Seynaeve, M J Hooning. Ann Oncol 2013
62
14

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
Inge-Marie Obdeijn, Gonneke A O Winter-Warnars, Ritse M Mann, Maartje J Hooning, M G Myriam Hunink, Madeleine M A Tilanus-Linthorst. Breast Cancer Res Treat 2014
35
25

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
194
9

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Xuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, Ellen Warner, Francesco Sardanelli, Martin O Leach, Christopher C Riedl, Isabelle Trop, Maartje J Hooning, Rodica Mandel,[...]. Br J Cancer 2016
46
19

Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
M J Stoutjesdijk, C Boetes, G J Jager, L Beex, P Bult, J H Hendriks, R J Laheij, L Massuger, L E van Die, T Wobbes,[...]. J Natl Cancer Inst 2001
227
8

MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
Christiane K Kuhl, Simone Schrading, Heribert B Bieling, Eva Wardelmann, Claudia C Leutner, Roy Koenig, Walther Kuhn, Hans H Schild. Lancet 2007
422
8

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Sylvia K Plevritis, Allison W Kurian, Bronislava M Sigal, Bruce L Daniel, Debra M Ikeda, Frank E Stockdale, Alan M Garber. JAMA 2006
179
8

Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy.
Vivianne Freitas, Anabel Scaranelo, Ravi Menezes, Supriya Kulkarni, David Hodgson, Pavel Crystal. Cancer 2013
30
26

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
914
8

Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Christopher C Riedl, Lothar Ponhold, Daniel Flöry, Michael Weber, Regina Kroiss, Teresa Wagner, Michael Fuchsjäger, Thomas H Helbich. Clin Cancer Res 2007
67
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.